These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3897068)

  • 21. Interferon in the management of chronic hepatitis B.
    Perrillo RP
    Dig Dis Sci; 1993 Apr; 38(4):577-93. PubMed ID: 8462360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human lymphoblastoid interferon for the treatment of chronic hepatitis B. A randomized controlled trial.
    Mazzella G; Saracco G; Rizetto M; Amed MA; Gonzàlez Quintela A; Rosina F; Barbara L; Roda E
    Am J Med; 1988 Aug; 85(2A):141-2. PubMed ID: 3044077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The delta agent in acute and chronic hepatitis B infection in Sweden.
    Norkrans G; Hermodsson S; Iwarson S
    Scand J Gastroenterol; 1983 Jul; 18(5):675-8. PubMed ID: 6675189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of children with chronic hepatitis B with a combination of steroids and human lymphoblastoid interferon.
    Giacchino R; Facco F; Giambartolomei G; Navone C; Timitilli A; Cirillo C; Barigione G; Terragna A
    Chemioterapia; 1988 Dec; 7 Suppl 3():20-5. PubMed ID: 3073870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of chronic delta hepatitis with recombinant human alpha interferon.
    Hoofnagle J; Mullen K; Peters M; Avigan M; Park Y; Waggoner J; Gerin J; Hoyer B; Smedile A
    Prog Clin Biol Res; 1987; 234():291-8. PubMed ID: 3628383
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of chronic hepatitis delta virus (HDV) infection with human lymphoblastoid alpha interferon.
    Farci P; Karayiannis P; Brook MG; Smedile A; Lai ME; Balestrieri A; Saldanha JA; Monjardino J; Gerin J; Thomas HC
    Q J Med; 1989 Nov; 73(271):1045-54. PubMed ID: 2623137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Delta hepatitis in Switzerland. Determination of delta antigens and delta antibodies in 397 HBsAg-positive patients (1978-1984)].
    Burkhardt F; Schilt U
    Schweiz Med Wochenschr; 1984 Jul; 114(30):1042-6. PubMed ID: 6474132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interferon antibodies in patients with chronic HBV infection treated with recombinant interferon.
    Porres JC; Carreño V; Ruíz M; Marrón JA; Bartolomé J
    J Hepatol; 1989 May; 8(3):351-7. PubMed ID: 2732449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The treatment of different forms of B and delta hepatitis with interferon preparations].
    Botsvadze ESh; Kuznetsov VP; Aleksishvili MM; Gogichaĭshvili ShSh
    Ter Arkh; 1991; 63(11):61-3. PubMed ID: 1810067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Leukinferon in the treatment of severe forms of acute hepatitis B].
    Botsvadze ESh; Kuznetsov VP; Gogichaĭshvili ShSh
    Ter Arkh; 1989; 61(11):50-4. PubMed ID: 2633393
    [No Abstract]   [Full Text] [Related]  

  • 31. Does delta agent contribute to fulminant hepatitis?
    Tabor E; Ponzetto A; Gerin JL; Gerety RJ
    Lancet; 1983 Apr; 1(8327):765-6. PubMed ID: 6132106
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of human fibroblast interferon (INF-beta) on hepatitis B virus DNA in serum.
    Vladutiu AO; Pudlak KA; Hammer M; Berninger M; Leibowitz AI
    Biomed Pharmacother; 1982; 36(3):162-4. PubMed ID: 7150711
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant fibroblast interferon and immune interferon for treating chronic hepatitis B virus infection: patients' tolerance and the effect on viral markers.
    Bissett J; Eisenberg M; Gregory P; Robinson WS; Merigan TC
    J Infect Dis; 1988 May; 157(5):1076-80. PubMed ID: 3129521
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of 28 consecutive days lymphoblastoid interferon (alpha-IFN) administration on hepatitis B virus related chronic liver disease.
    Franco A; Barnaba V; Levrero M; Ruberti G; Van Dyke A; Bonavita MS; Balsano F
    J Hepatol; 1986; 3 Suppl 2():S239-43. PubMed ID: 3298412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis B virus-associated coinfection and superinfection with delta agent: indistinguishable disease with different outcome.
    Caredda F; Rossi E; d'Arminio Monforte A; Zampini L; Re T; Meroni B; Moroni M
    J Infect Dis; 1985 May; 151(5):925-8. PubMed ID: 3989325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of chronic hepatitis B with human lymphoblastoid interferon: results of a controlled trial.
    Mazzella G; Villanova N; Abdu-Ahmed M; Barbara L; Saracco G; Rizzetto M; Cancellieri C; Roda E
    Chemioterapia; 1988 Dec; 7 Suppl 3():12-4. PubMed ID: 3073868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A controlled trial of 6 months thrice weekly lymphoblastoid interferon versus no therapy in chronic hepatitis B virus infection. A preliminary analysis of the first 32 patients.
    Alexander GJ; Fagan EA; Guarner P; Rolando N; Brahm J; Eddleston AL; Williams R
    J Hepatol; 1986; 3 Suppl 2():S183-8. PubMed ID: 3298406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Permanent inhibition of viral replication induced by low dosage of human leukocyte interferon in patients with chronic hepatitis B.
    Pastore G; Santantonio T; Monno L; Milella M; Luchena N; Angarano G
    Hepatogastroenterology; 1988 Apr; 35(2):57-61. PubMed ID: 3371847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autoantibodies before, during and after administration of recombinant interferon-alpha for chronic viral hepatitis.
    Lopes EP; Silva AE; Sette Junior H; Guimarães RX; Ferraz ML
    Rev Inst Med Trop Sao Paulo; 1995; 37(5):455-60. PubMed ID: 8729757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fulminant delta hepatitis in chronic hepatitis B infection.
    De Cock KM; Govindarajan S; Redeker AG
    JAMA; 1984 Nov; 252(19):2746-8. PubMed ID: 6387205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.